Personalized follow-up care for head and neck cancer patients
Evaluation of the Implementation of Personalised Follow-up in Head and Neck Cancer
This study is testing a personalized follow-up care program for people who have finished treatment for head and neck cancer to see how it can improve their experience and quality of life.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 33 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Guy's and St Thomas' NHS Foundation Trust Academic / other |
| Locations | 1 site (London) |
| Trial ID | NCT06170203 on ClinicalTrials.gov |
What this trial studies
This observational study evaluates the implementation of a Personalized Follow-Up (PFU) program for patients who have completed treatment for head and neck cancer. The study aims to identify barriers and facilitators to effectively deliver tailored follow-up care, enhancing patient experience and quality of life. Data will be collected through questionnaires and qualitative interviews with patients and healthcare providers to assess the impact of PFU on their care journey. The research will ensure ethical standards are maintained, with a focus on informed consent and participant confidentiality.
Who should consider this trial
Good fit: Ideal candidates are patients who have completed curative treatment for head and neck cancer, are disease-free, and at least two years post-treatment.
Not a fit: Patients with active disease, significant risk factors for recurrence, or severe treatment-related toxicity may not benefit from this study.
Why it matters
Potential benefit: If successful, this program could significantly improve the quality of life and care experience for head and neck cancer survivors.
How similar studies have performed: While PFU programs have been established for other cancer types, this specific implementation for head and neck cancer is novel and has not been extensively tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Patient inclusion criteria * Patients referred to the Head and Neck Cancer Personalised Follow Up clinic * Patients who had oncological treatment for a Head and Neck cancer * Patients who were treated with curative intent and who are disease free * Patients who are at least 2 years post treatment completion * Patients who have no risk factors of disease recurrence Staff Criteria * Oncologists, surgeons, allied health practitioners, nurses, and support staff who provide care for patients with Head and Neck Cancer * Willing to participate in a qualitative interview or focus group
Where this trial is running
London
- Laura Dean — London, United Kingdom (Recruiting)
Study contacts
- Study coordinator: Laura Dean
- Email: laura.dean@gstt.nhs.uk
- Phone: +447391661798
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.